Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Gen Surg Vivasvascular

Gen Surg Vivas · vascular

Ruptured AAA at 2am — endovascular-first strategy, the 8-year crossover and the female threshold gap

Fellowship viva on ruptured AAA: IMPROVE endovascular-first strategy with 30-day to 3-year numbers, reintervention burden, EVAR durability crossover, and the unverified female threshold.

clinical2 min readVerification in progress

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
On this page
Study tools

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
Prompt
A 74-year-old man arrives at 2am with sudden back pain, hypotension and a known 7 cm AAA. His 70-year-old wife, who has a 5.1 cm AAA herself, asks whether her threshold is the same. Talk me through your rupture strategy with the IMPROVE time course, what the 15-year EVAR crossover means for a survivor, and what you tell her about her number.

Write your answer

Saved on this device. No marking — you are the marker.

Examiner prompts and model answers

He is hypotensive with a known 7 cm AAA at 2am — what is your strategy, and what does IMPROVE say it buys? Run the endovascular-first strategy if anatomy suits and the service exists: IMPROVE randomised 613 suspected ruptures and tied at 30 days (35.4 versus 37.4%, OR 0.92) with more patients home directly (94 versus 77%).[14] At 1 year still tied on death (41.1 versus 45.1%) but with 17-versus-26-day stays, better quality of life and cost-effectiveness; at 3 years the strategy pulls ahead (48 versus 56%, 42 versus 54% in repaired ruptures) with tied reinterventions, QALY gains and lower costs — converging again by 7 years.[15][16] Open repair where EVAR is unsuitable — only 174 of 275 confirmed ruptures qualified — and consent for reintervention as the norm.[14]

He survives EVAR for rupture — what does the 15-year elective crossover mean for his follow-up? That his danger is not over: beyond 8 years open repair beats EVAR on total and aneurysm-related death (HR 1.25 and 5.82), driven by secondary sac rupture (13 versus 2 deaths), so he enters lifelong surveillance with reintervention — and post-rupture reintervention runs hotter than elective, with 13% needing mid-term reintervention mostly for endoleak, mandating bespoke protocols.[10][17]

His wife asks whether her 5.1 cm threshold is the same as his — what do you tell her? That her number has no trial behind it: the surveillance-versus-repair randomisation ran primarily in men, her disease grows faster, ruptures smaller and repairs worse — so she is individualised early with vascular surgery on anatomy and fitness, and if she ruptures, the endovascular strategy carries a possible female advantage (OR 0.44 versus 1.18, interaction P 0.02) that still needs confirmation.[26][14]

Which guideline are you following tonight, and why does NICE disagree with ESVS? ESVS 2024 frames the night — 160 recommendations covering permissive hypotension, aortic balloon occlusion, compartment syndrome and colonic ischaemia through to graft infection and endoleak follow-up.[22] The NICE-versus-ESVS split is methodological: NICE runs open-first for elective AAA on old RCTs plus UK modelling (and open repair for ruptured men under 71 the same way), while ESVS runs EVAR-first on modern observational evidence — know both, follow your service's pathway, and never present one as error.[23]

References8ShowHide
  1. [14]Powell JT, et al. Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ, 2014.PMID 24418950
  2. [15]IMPROVE Trial Investigators Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: one-year outcomes from the IMPROVE randomized trial. Eur Heart J, 2015.PMID 25855369
  3. [16]IMPROVE Trial Investigators Comparative clinical effectiveness and cost effectiveness of endovascular strategy v open repair for ruptured abdominal aortic aneurysm: three year results of the IMPROVE randomised trial. BMJ, 2017.PMID 29138135
  4. [17]Powell JT, et al. Editor's Choice - Re-interventions After Repair of Ruptured Abdominal Aortic Aneurysm: A Report From the IMPROVE Randomised Trial. Eur J Vasc Endovasc Surg, 2018.PMID 29503083
  5. [10]Patel R, et al. Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet, 2016.PMID 27743617
  6. [22]Wanhainen A, et al. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. Eur J Vasc Endovasc Surg, 2024.PMID 38307694
  7. [23]Powell JT, et al. Analysis of the Differences Between the ESVS 2019 and NICE 2020 Guidelines for Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg, 2020.PMID 32439141
  8. [26]Deery SE, et al. Should Abdominal Aortic Aneurysms in Women be Repaired at a Lower Diameter Threshold? Vasc Endovascular Surg, 2018.PMID 29720046
PreviousIntermediate-risk PE with RV strain and a bleeding history — systemic lysis versus catheter versus anticoagulation, consent, and the long-term picturevascularNextARDS in the surgical patient — define, ventilate, rescue with the trialssurgical-critical-care